SKN | BMO Gains Regulatory Clearance for a New 25 Million-Share Buyback

Key Takeaways:

• Bank of Montreal has received TSX and OSFI approval to repurchase up to 25 million common shares for cancellation.
• The program can begin on September 8, 2026 and continue through September 7, 2027, giving management additional flexibility over capital deployment.
• The authorization represents approximately 3.6% of BMO’s public float and issued common shares as of August 31.
• The key signal is not the maximum volume itself, but BMO’s ability to calibrate repurchases against market conditions and capital adequacy.

Bank of Montreal (BMO) has secured regulatory approval for a new normal course issuer bid, allowing the bank to repurchase up to 25 million common shares for cancellation. Approval from both the Toronto Stock Exchange and the Office of the Superintendent of Financial Institutions removes the principal regulatory condition attached to the program.

The authorization represents approximately 3.6% of BMO’s public float and issued common shares based on the bank’s position at August 31. More importantly, the program gives management another instrument for managing excess capital while preserving flexibility around the timing of shareholder distributions.

BMO Creates Greater Flexibility in Capital Allocation

The new buyback is scheduled to commence on September 8, 2026 and run no later than September 7, 2027. BMO has made clear that authorization does not mean the bank must repurchase the full 25 million shares. The actual volume, timing and purchase price will remain subject to management discretion, with decisions influenced by market conditions and capital adequacy.

BMO will also establish an automatic securities purchase plan through BMO Nesbitt Burns. This provides a defined mechanism for purchases during periods when management’s pre-established criteria are met, while maintaining the bank’s broader discretion over capital deployment.

The New Program Extends BMO’s Existing Buyback Discipline

The approval arrives as BMO’s previous 30 million-share NCIB reaches its scheduled end on September 4. As of August 31, the bank had already repurchased 23.67 million shares under that program at a volume-weighted average price of approximately $197.76 per share.

That history provides important context. BMO is not introducing repurchases as a one-off capital action; it is establishing continuity in its approach to returning excess capital through share cancellations.

Why the Decision Matters for Long-Term Capital Holders

For sophisticated investors, the strategic value of the authorization lies in the optionality it creates. A bank can use repurchases when capital levels, valuation and operating conditions make them appropriate, while retaining the ability to moderate purchases when balance-sheet requirements become more demanding.

BMO reported 695.1 million common shares outstanding at August 31, meaning the authorized maximum is meaningful but remains a measured proportion of the bank’s equity base. The program therefore appears structured as a capital-management tool rather than an aggressive commitment to shrink the share count.

For globally diversified wealth holders, the distinction is important. Capital allocation discipline matters as much as headline shareholder returns, particularly for systemically important financial institutions operating across multiple jurisdictions. BMO’s next test will be how management balances repurchases with capital adequacy, lending capacity and other strategic uses of balance-sheet strength. For a confidential discussion regarding your cross-border banking structure and financial-sector exposure, contact our senior advisory team.